Countries Allowed: United States
Viviomd is a Delaware-based digital intake and marketing platform founded in 2024 that connects patients with licensed medical providers for GLP-1 weight loss treatments.
The primary audience includes adults aged 25 to 60 seeking medical weight loss solutions, particularly those interested in alternatives to traditional injectables, such as Oral Disintegrating Tablets (ODTs) and liquid formulas.
Get More Info: 👇
No comments:
Post a Comment